{"id":"aspirin-treatment","safety":{"commonSideEffects":[{"rate":"1-3","effect":"Gastrointestinal bleeding or ulceration"},{"rate":"5-10","effect":"Dyspepsia"},{"rate":"2-5","effect":"Nausea"},{"rate":"<1","effect":"Hemorrhagic stroke (at higher doses)"},{"rate":"<1","effect":"Allergic reactions/bronchospasm"},{"rate":"1-2","effect":"Renal impairment (chronic use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin acetylates serine residues on COX-1 and COX-2 enzymes, permanently blocking their catalytic activity. This prevents the synthesis of thromboxane A2 in platelets, which is essential for platelet activation and clot formation, thereby reducing thrombotic events. Additionally, aspirin's anti-inflammatory effects stem from inhibition of prostaglandin production in various tissues.","oneSentence":"Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing the production of thromboxane A2 and other prostaglandins to decrease platelet aggregation and inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:42:46.713Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction prevention and secondary prevention"},{"name":"Ischemic stroke prevention"},{"name":"Transient ischemic attack (TIA) prevention"},{"name":"Unstable angina"},{"name":"Pain and fever relief"},{"name":"Rheumatoid arthritis and other inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT03654105","phase":"PHASE2","title":"Screening and Multiple Intervention on Lung Epidemics","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","startDate":"2019-07-23","conditions":"Inflammation, Smoking Cessation, Diet Modification","enrollment":2000},{"nctId":"NCT07494877","phase":"","title":"Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT02965703","phase":"PHASE2","title":"Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-16","conditions":"Colorectal Adenoma, Colorectal Carcinoma","enrollment":81},{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340},{"nctId":"NCT05521776","phase":"NA","title":"Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-06","conditions":"Preeclampsia (PE)","enrollment":14500},{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT07496281","phase":"PHASE4","title":"OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation","status":"NOT_YET_RECRUITING","sponsor":"Ewha Womans University Mokdong Hospital","startDate":"2027-03-01","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease, Drug-eluting Stent","enrollment":2},{"nctId":"NCT05387954","phase":"PHASE3","title":"PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-07-07","conditions":"Cryptogenic Ischemic Stroke, Patent Foramen Ovale","enrollment":792},{"nctId":"NCT01731236","phase":"EARLY_PHASE1","title":"CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2011-02-11","conditions":"Dietary Modification","enrollment":100},{"nctId":"NCT02875353","phase":"NA","title":"Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2017-02-15","conditions":"Delayed Post-Polypectomy Induced Ulcer Hemorrhage","enrollment":180},{"nctId":"NCT07480629","phase":"","title":"The 10-Year Extended Follow-up of the DACAB Trial","status":"ENROLLING_BY_INVITATION","sponsor":"Ruijin Hospital","startDate":"2026-03-15","conditions":"Coronary Artery Disease, CABG, Antiplatelet Therapy of Coronary Artery Bypass","enrollment":500},{"nctId":"NCT07476898","phase":"PHASE3","title":"Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window","status":"NOT_YET_RECRUITING","sponsor":"First Hospital of China Medical University","startDate":"2026-03-01","conditions":"Stroke","enrollment":864},{"nctId":"NCT07456085","phase":"PHASE3","title":"Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves","status":"ENROLLING_BY_INVITATION","sponsor":"Rawalpindi Institute of Cardiology","startDate":"2025-11-13","conditions":"Valvular Heart Disease Patients","enrollment":60},{"nctId":"NCT07089862","phase":"NA","title":"INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-08-31","conditions":"Unruptured Intracranial Aneurysm, Indobufen","enrollment":2500},{"nctId":"NCT06906939","phase":"EARLY_PHASE1","title":"A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-04-01","conditions":"Knee Osteoarthritis, Depression","enrollment":30},{"nctId":"NCT02647099","phase":"PHASE3","title":"Adjuvant Low Dose Aspirin in Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anna Martling","startDate":"2016-04-07","conditions":"Colorectal Cancer","enrollment":626},{"nctId":"NCT00713947","phase":"PHASE4","title":"Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-04","conditions":"Positive Helicobacter Pylori Serology, Coronary Thrombosis, Supra-aortic Artery Thrombosis","enrollment":""},{"nctId":"NCT06451198","phase":"PHASE4","title":"IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-05-19","conditions":"Coronary Artery Disease, Antiplatelet Drugs","enrollment":2846},{"nctId":"NCT04295486","phase":"PHASE2","title":"Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty","status":"RECRUITING","sponsor":"University of Miami","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":5478},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT05633810","phase":"PHASE3","title":"COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2022-12-21","conditions":"Diabete Type 2, Cardiovascular Diseases","enrollment":10000},{"nctId":"NCT07257198","phase":"PHASE3","title":"Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone","status":"RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2026-03-03","conditions":"NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction","enrollment":2570},{"nctId":"NCT07007143","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-07-31","conditions":"Mitral Regurgitation","enrollment":1032},{"nctId":"NCT05681702","phase":"PHASE4","title":"Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI","status":"RECRUITING","sponsor":"University of Florida","startDate":"2023-02-15","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT06901466","phase":"PHASE4","title":"STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2025-06-13","conditions":"Mitral Regurgitation","enrollment":880},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT03553563","phase":"PHASE3","title":"A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-07-24","conditions":"Reflux Esophagitis, Gastric Ulcer, Duodenal Ulcer","enrollment":50},{"nctId":"NCT06037889","phase":"PHASE3","title":"Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2023-11-09","conditions":"Branch Atheromatous Disease","enrollment":516},{"nctId":"NCT07444164","phase":"PHASE1","title":"Comparative Bioavailability Study Between Ticagrelor and ASA Administered Individually or in Combination.","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2025-01-13","conditions":"Healthy","enrollment":24},{"nctId":"NCT07441382","phase":"NA","title":"Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-01","conditions":"Atrial Fibrillation (AF), Stroke, Hemorrhage","enrollment":200},{"nctId":"NCT05761015","phase":"PHASE4","title":"Helping Osteoarthritis Patients to Walk With NSAID","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-12-14","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip, Chronic Pain","enrollment":55},{"nctId":"NCT07432516","phase":"NA","title":"Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2026-02","conditions":"Coronary Artery Disease","enrollment":4400},{"nctId":"NCT06588595","phase":"PHASE4","title":"The Switching Antiplatelet-9 (SWAP-9) Study","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-11-01","conditions":"Coronary Arterial Disease (CAD)","enrollment":90},{"nctId":"NCT07431762","phase":"PHASE4","title":"Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Heart Valve Replacement","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-02-01","conditions":"Valve Replacement Surgery","enrollment":1058},{"nctId":"NCT03295773","phase":"","title":"Morphologic Evolution and Remodeling of Intracranial Atherosclerosis: A Longitudinal Study by 3D-rotational Angiography","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2016-08-22","conditions":"Ischemic Stroke, Atheroscleroses, Cerebral","enrollment":140},{"nctId":"NCT05531474","phase":"NA","title":"Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2020-11-02","conditions":"Cardiovascular Complication, Bariatric Surgery Candidate","enrollment":200},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT07281547","phase":"PHASE4","title":"Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-08-12","conditions":"Endometrial Carcinoma","enrollment":25},{"nctId":"NCT06543082","phase":"PHASE4","title":"MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study","status":"RECRUITING","sponsor":"CHA University","startDate":"2024-08-05","conditions":"Acute Coronary Syndrome","enrollment":490},{"nctId":"NCT02945033","phase":"PHASE3","title":"Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2018-07-12","conditions":"Colorectal Cancer","enrollment":264},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT07205250","phase":"EARLY_PHASE1","title":"Aspirin for Prevention of Stroke After Endovascular Aortic Arch Repair: a Multicenter, Double-Blind, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"The General Hospital of Western Theater Command","startDate":"2026-02-20","conditions":"Type B or Non-A Non-B Aortic Dissection;Thoracic Aortic Aneurysm","enrollment":224},{"nctId":"NCT00646906","phase":"NA","title":"Mechanisms of Action of Acetaminophen","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2004-06-02","conditions":"Myocardial Infarction, Arthritis","enrollment":55},{"nctId":"NCT05707442","phase":"PHASE3","title":"Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2023-02-16","conditions":"Idiopathic Intracranial Hypotension, Venous Sinus Stenosis","enrollment":74},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT07243704","phase":"PHASE3","title":"Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Christian Medical College and Hospital, Ludhiana, India","startDate":"2026-02-15","conditions":"Intracerebral Haemorrhage","enrollment":5676},{"nctId":"NCT06728072","phase":"PHASE2","title":"Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2025-03-07","conditions":"Colorectal Cancer, CRC","enrollment":97},{"nctId":"NCT06717776","phase":"NA","title":"Effects of Compensation-Based Problem Solving Therapy","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2024-09-01","conditions":"Stroke","enrollment":52},{"nctId":"NCT04014803","phase":"PHASE4","title":"Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2020-01-13","conditions":"Coronary Artery Disease","enrollment":3500},{"nctId":"NCT01275300","phase":"NA","title":"Biosynthesis of PGD2 in Vivo","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2007-07","conditions":"Hyperlipidemia","enrollment":9},{"nctId":"NCT06691191","phase":"PHASE4","title":"Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors","status":"RECRUITING","sponsor":"University of Florida","startDate":"2025-01-08","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT06228456","phase":"PHASE4","title":"Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-04-01","conditions":"Coronary Artery Disease","enrollment":50},{"nctId":"NCT06281665","phase":"PHASE4","title":"Treatment With Aspirin After Preeclampsia: TAP Trial","status":"RECRUITING","sponsor":"Malamo Countouris","startDate":"2024-05-29","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":60},{"nctId":"NCT07390513","phase":"","title":"Electrophysiological Outcomes After Transcatheter Aortic Valve Replacement","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2022-01-01","conditions":"Aortic Valve Stenosis, Arrhythmia","enrollment":1000},{"nctId":"NCT07379190","phase":"PHASE3","title":"HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)","status":"NOT_YET_RECRUITING","sponsor":"Weifang Medical University","startDate":"2026-02-01","conditions":"Stroke, Acute, Stroke, Ischemic, Cerebral Infarction","enrollment":458},{"nctId":"NCT07385300","phase":"NA","title":"Omega-3 Pufa and Aspirin as Adjunctive Therapy in Treatment of Smoker Patients With Stage Iii Periodontitis","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2023-08-20","conditions":"Periodontitis, Diabete Mellitus","enrollment":45},{"nctId":"NCT07111559","phase":"PHASE4","title":"Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial","status":"RECRUITING","sponsor":"Nippon Medical School","startDate":"2025-08-01","conditions":"Lacunar Stroke, Stroke, Ischemic Stroke","enrollment":500},{"nctId":"NCT04184921","phase":"PHASE2","title":"Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients","status":"COMPLETED","sponsor":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","startDate":"2019-01-01","conditions":"Lung Cancer Non-small Cell Stage IV","enrollment":216},{"nctId":"NCT07378228","phase":"NA","title":"Weak Pulse at Yang and Wiry Pulse at Yin Theory","status":"COMPLETED","sponsor":"Xikun Li","startDate":"2023-07-01","conditions":"Coronary Heart Disease, Stable Angina Pectoris","enrollment":70},{"nctId":"NCT05785897","phase":"NA","title":"STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT","status":"RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2025-11-01","conditions":"ST Elevation Myocardial Infarction","enrollment":350},{"nctId":"NCT05868525","phase":"PHASE4","title":"Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).","status":"RECRUITING","sponsor":"Loma Linda University","startDate":"2023-08-23","conditions":"Blunt Cerebrovascular Injury","enrollment":98},{"nctId":"NCT06676280","phase":"PHASE4","title":"ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography","status":"RECRUITING","sponsor":"Jung-min Ahn","startDate":"2025-07-24","conditions":"Cardiovascular Diseases","enrollment":5000},{"nctId":"NCT04698031","phase":"PHASE4","title":"Efficacy of Clopidogrel on Incidence of Silent Brain Infarction","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-03-30","conditions":"Silent Brain Infarction","enrollment":134},{"nctId":"NCT07374718","phase":"NA","title":"Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-03-01","conditions":"Acute Coronary Syndrome (ACS), High Bleeding Risk(HBR), Coronary Artery Disease (CAD)","enrollment":468},{"nctId":"NCT03250247","phase":"NA","title":"Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2018-07-02","conditions":"Deep Vein Thrombosis, Venous Stasis, Venous Insufficiency","enrollment":225},{"nctId":"NCT04284397","phase":"EARLY_PHASE1","title":"Identification of Critical Thermal Environments for Aged Adults","status":"RECRUITING","sponsor":"Penn State University","startDate":"2020-12-30","conditions":"Aging","enrollment":190},{"nctId":"NCT04040452","phase":"PHASE4","title":"Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery","status":"RECRUITING","sponsor":"Phoenix Children's Hospital","startDate":"2021-03-01","conditions":"Congenital Heart Disease in Children","enrollment":166},{"nctId":"NCT03590821","phase":"EARLY_PHASE1","title":"Timed Aspirin Chronobiome Study","status":"NOT_YET_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2027-12","conditions":"Healthy","enrollment":60},{"nctId":"NCT07361679","phase":"PHASE4","title":"LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention","status":"RECRUITING","sponsor":"Alexandra Hospital, Athens, Greece","startDate":"2023-01-18","conditions":"Preeclampsia Severe, Toxemia Of Pregnancy, Preeclampsia","enrollment":100},{"nctId":"NCT06535568","phase":"NA","title":"Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)","status":"RECRUITING","sponsor":"Fondazione Ricerca e Innovazione Cardiovascolare ETS","startDate":"2026-01-10","conditions":"Coronary Disease, Heart Diseases, Cardiovascular Diseases","enrollment":576},{"nctId":"NCT06930885","phase":"PHASE3","title":"Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease","status":"RECRUITING","sponsor":"Hospital do Coracao","startDate":"2025-06-12","conditions":"Atherothrombotic Diseases, Atherosclerotic Cardiovascular Disease (ASCVD)","enrollment":7713},{"nctId":"NCT06316570","phase":"PHASE3","title":"Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2024-04-03","conditions":"Ischemic Stroke, Acute","enrollment":1382},{"nctId":"NCT07358416","phase":"","title":"Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Petrovsky National Research Centre of Surgery","startDate":"2025-05-01","conditions":"Thrombosis, Bleeding, Cerebral Hypoxia During and/or Resulting From A Procedure","enrollment":500},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT06915428","phase":"NA","title":"Personalized Care for Prenatal Stress Reduction & Prevention of Preterm Birth (PTB) Disparities","status":"NOT_YET_RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-02-01","conditions":"Preterm Birth Complication, Preterm Birth, Preterm Birth Recurrence","enrollment":1228},{"nctId":"NCT04708587","phase":"NA","title":"Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2021-03-23","conditions":"Chronic Kidney Diseases","enrollment":900},{"nctId":"NCT06315530","phase":"PHASE2","title":"Effect of Telitacicept on Antibody Titers in Primary APS Patients","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2023-12-01","conditions":"Antiphospholipid Syndrome (APS)","enrollment":20},{"nctId":"NCT07032389","phase":"PHASE2","title":"A Polypill for Acute Coronary Syndrome","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2025-12-05","conditions":"Acute Coronary Syndrome","enrollment":1000},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":3826},{"nctId":"NCT05577988","phase":"PHASE3","title":"Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-06-18","conditions":"MYOCARDIAL INFARCTION","enrollment":2468},{"nctId":"NCT07347626","phase":"PHASE3","title":"Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis","status":"NOT_YET_RECRUITING","sponsor":"Xinqiao Hospital of Chongqing","startDate":"2026-03-01","conditions":"Acute Ischemic Stroke","enrollment":786},{"nctId":"NCT07113158","phase":"PHASE3","title":"Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Sudden Sensorineural Hearing Loss","enrollment":142},{"nctId":"NCT07338331","phase":"NA","title":"Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Galala University","startDate":"2023-04-04","conditions":"Diabete Type 2, Non Alcoholic Fatty Liver","enrollment":80},{"nctId":"NCT07337655","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-10-01","conditions":"Pre-term Birth","enrollment":670},{"nctId":"NCT05310968","phase":"PHASE4","title":"Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2022-11-12","conditions":"Branch Atheromatous Disease","enrollment":970},{"nctId":"NCT06076837","phase":"PHASE1","title":"The Seven Trial: Exploiting the Unfolded Protein Response","status":"ACTIVE_NOT_RECRUITING","sponsor":"HonorHealth Research Institute","startDate":"2025-01-09","conditions":"Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic","enrollment":6},{"nctId":"NCT05080946","phase":"EARLY_PHASE1","title":"Using Aspirin to Improve Immunological Features of Ovarian Tumors","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2021-11-02","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer","enrollment":100},{"nctId":"NCT05493657","phase":"NA","title":"Aspirin vs Clopidogrel After TAVR","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-02-02","conditions":"Severe Aortic Stenosis","enrollment":254},{"nctId":"NCT07076082","phase":"PHASE4","title":"Vascular Trial Associated Registry Pilot","status":"RECRUITING","sponsor":"Corewell Health West","startDate":"2025-10-15","conditions":"Peripheral Arterial Disease","enrollment":350},{"nctId":"NCT07086183","phase":"","title":"Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-12-01","conditions":"Aneurysm Cerebral","enrollment":100},{"nctId":"NCT06937372","phase":"NA","title":"Delivery and Implementation of a Randomised Crossover Trial on Thrombosis","status":"NOT_YET_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2026-08-01","conditions":"Hip Fractures, Venous Thromboembolism (VTE)","enrollment":21194},{"nctId":"NCT05557877","phase":"PHASE2","title":"Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-03-09","conditions":"Breast Carcinoma","enrollment":100},{"nctId":"NCT07195149","phase":"PHASE3","title":"Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)","status":"RECRUITING","sponsor":"Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.","startDate":"2025-11-25","conditions":"Chronic Coronary Syndrome, Stable Coronary Artery Disease CAD","enrollment":1703},{"nctId":"NCT06210633","phase":"","title":"Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke","status":"RECRUITING","sponsor":"Zhongming Qiu","startDate":"2024-01-20","conditions":"Acute Ischemic Stroke (AIS), Acute Ischemic Stroke From Large Vessel Occlusion","enrollment":1000},{"nctId":"NCT07297576","phase":"NA","title":"Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-22","conditions":"ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia, MDS (Myelodysplastic Syndrome)","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1559,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Aspirin treatment","genericName":"Aspirin treatment","companyName":"VA Office of Research and Development","companyId":"va-office-of-research-and-development","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing the production of thromboxane A2 and other prostaglandins to decrease platelet aggregation and inflammation. Used for Acute myocardial infarction prevention and secondary prevention, Ischemic stroke prevention, Transient ischemic attack (TIA) prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}